Authors:
Salvador, A
Garcia-Paramio, MP
Sanchez-Chapado, M
Carmena, MJ
Prieto, JC
Citation: A. Salvador et al., Effects of the luteinising hormone-releasing hormone (LH-RH) agonist leuprolide on adenylyl cyclase regulation through G-protein coupled receptors inrat ventral prostate, EUR J CANC, 37(5), 2001, pp. 641-648
Authors:
Wirth, M
Tyrrell, C
Wallace, M
Delaere, KP
Sanchez-Chapado, M
Ramon, J
Hetherington, J
Pina, F
Heynes, CF
Borchers, TM
Morris, T
Stone, A
Citation: M. Wirth et al., Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression, UROLOGY, 58(2), 2001, pp. 146-150
Authors:
Royuela, M
de Miguel, MP
Bethencourt, FR
Sanchez-Chapado, M
Fraile, B
Arenas, MI
Paniagua, R
Citation: M. Royuela et al., Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate, J ENDOCR, 168(3), 2001, pp. 447-454
Authors:
Sanchez-Chapado, M
Guil, M
Badiella, LI
Fernandez-Hernando, N
Alfaro, V
Citation: M. Sanchez-chapado et al., The clinical uroselectivity of alfuzosin is not significantly affected by the age of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia, BJU INT, 86(4), 2000, pp. 432-438
Authors:
Montalvo, L
Carmena, MJ
Solano, RM
Clemente, C
Roman, ID
Sanchez-Chapado, M
Prieto, JC
Citation: L. Montalvo et al., Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostate, CELL SIGNAL, 12(5), 2000, pp. 311-316
Authors:
Sanchez-Chapado, M
Guil, M
Alfaro, V
Badiella, L
Fernandez-Hernando, N
Citation: M. Sanchez-chapado et al., Safety and efficacy of sustained-release alfuzosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia in 3,095 Spanish patients evaluated during general practice, EUR UROL, 37(4), 2000, pp. 421-427
Authors:
Solano, RM
Garcia-Fernandez, MO
Clemente, C
Querol, M
Bellamy, F
Sanchez-Chapado, M
Prieto, JC
Carmena, MJ
Citation: Rm. Solano et al., Effects of Pygeum africanum extract (Tadenan (R)) on vasoactive intestinalpeptide receptors, G proteins, and adenylyl cyclase in rat ventral prostate, PROSTATE, 45(3), 2000, pp. 245-252
Authors:
Solano, RM
Carmena, MJ
Busto, R
Sanchez-Chapado, M
Guijarro, LG
Prieto, JC
Citation: Rm. Solano et al., Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC(1)) receptor in human benign hyperplastic prostate, CELL SIGNAL, 11(11), 1999, pp. 813-819
Authors:
Garcia-Segura, JM
Sanchez-Chapado, M
Ibarburen, C
Viano, J
Angulo, JC
Gonzalez, J
Rodriguez-Vallejo, JM
Citation: Jm. Garcia-segura et al., In vivo proton magnetic resonance spectroscopy of diseased prostate: Spectroscopic features of malignant versus benign pathology, MAGN RES IM, 17(5), 1999, pp. 755-765
Authors:
Angulo, JC
Lopez-Rubio, M
Guil, M
Herrero, B
Burgaleta, C
Sanchez-Chapado, M
Citation: Jc. Angulo et al., The value of comparative volumetric analysis of urinary and blood erythrocytes to localize the source of hematuria, J UROL, 162(1), 1999, pp. 119-126
Authors:
Royuela, M
De Miguel, MP
Bethencourt, FR
Sanchez-Chapado, M
Fraile, B
Paniagua, R
Citation: M. Royuela et al., Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma, GROW FACTOR, 16(2), 1998, pp. 101-110